SCHEMBL3367824

SCHEMBL3367824

O=C(O)CCCCCCC/C=C\C/C=C\CCCCCC(O)CO

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 5/20 0.60
▸ FFAR4 Q5NUL3 3/20 0.60
▸ ALDH1A1 P00352 7/20 0.58
▸ F7 P08709 6/20 0.58
▸ F3 P13726 6/20 0.58
▸ PPARG P37231 5/20 0.58
▸ PPARD Q03181 4/20 0.58
▸ PPARA Q07869 4/20 0.58
▸ CYP19A1 P11511 3/20 0.58
▸ PTGS1 P23219 3/20 0.58
▸ OXER1 Q8TDS5 2/20 0.58
▸ MAPT P10636 2/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ LMNA P02545 2/20 0.58
▸ CYP3A4 P08684 2/20 0.58
▸ HPGD P15428 2/20 0.58
▸ ALOX15 P16050 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30902072 0.95 FFAR1 (0.65) FFAR1FFAR4F7F3PPARG
SCHEMBL3683366 0.95 FFAR1 (0.65) FFAR1FFAR4F7F3PPARG
SCHEMBL162101 0.95 FFAR1 (0.65) FFAR1FFAR4F7F3PPARG
Ethylene SCHEMBL10697177 0.92 FFAR1 (0.61) FFAR1FFAR4F7F3PPARG
Ethylene Glycol SCHEMBL20678202 0.92 FFAR1 (0.61) FFAR1FFAR4F7F3PPARG
SCHEMBL30951731 0.92 FFAR1 (0.65) FFAR1FFAR4ALDH1A1F7F3
Oleic Acid SCHEMBL29894126 0.86 FFAR1 (0.76) FFAR1FFAR4ALDH1A1F7F3
SCHEMBL30457930 0.86 FFAR1 (0.71) FFAR1FFAR4F7F3PPARG
SCHEMBL30458046 0.86 FFAR1 (0.71) FFAR1FFAR4F7F3PPARG
SCHEMBL10081556 0.86 FFAR1 (0.71) FFAR1FFAR4F7F3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303596-B1 MORPHOLINO ANTISENSE OLIGOMERS AS ENZYME INHIBITORS FOR IMPROVING PHARMACOKINETICS OF A DRUG UNIV NEBRASKA (US) 2010-09-15 — — EP disclosed
US-20040229829-A1 Enzyme inhibitors for metabolic redirection THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2004-11-18 — — US disclosed
US-6673778-B1 ADMINISTERING TRANSDERMALLY MORPHOLINO ANTISENSE OLIGOMER TO REDUCE EXPRESSION OF CYTOCHROME P450 ENZYME THAT CATALYZES METABOLISM OF DRUG, BY HYBRIDIZING TO TARGET RNA MOLECULE WHICH ENCODES ENZYME, THUS INHIBITING METABOLISM OF DRUG THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2004-01-06 — — US disclosed
EP-1303596-A2 ANTISENSE ENZYME INHIBITORS FOR IMPROVING PHARMACOKINETICS OF A DRUG Avi Biopharma, Inc. (US) 2003-04-23 — — EP disclosed
WO-2001087286-A2 ANTISENSE ENZYME INHIBITORS FOR IMPROVING PHARMACOKINETICS OF A DRUG AVI BIOPHARMA, INC. (US) 2001-11-22 — — WO disclosed
Send feedback